XNYS
NVST
Market cap3.75bUSD
Oct 07, Last price
23.04USD
1D
-0.99%
1Q
-10.56%
IPO
-17.71%
Name
Envista Holdings Corp
Chart & performance
P/E
79.77
P/S
1.38
EPS
0.29
Div yield, %
—
Shrs. gr., 5y
0.61%
Rev. gr., 5y
7.11%
Revenues
2.72b
+8.32%
Net income
47m
P
CFO
276m
-18.07%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Envista Holdings Corp. is a dental solutions provider based in Brea, California, employing 12,800 individuals. The company develops, manufactures, and markets a comprehensive range of products aimed at diagnosing, treating, and preventing various dental conditions affecting the teeth, gums, and surrounding bone structures. Its operations are divided into two primary segments. The first, "Specialty Products & Technologies," is dedicated to creating and distributing advanced items such as dental implant systems, prosthetics, associated treatment software, orthodontic bracket systems, aligners, and laboratory products. Meanwhile, the "Equipment & Consumables" segment provides essential tools and supplies for dental offices, encompassing digital imaging and visualization systems, treatment units, other general practice equipment, endodontic systems and consumables, restorative materials, instruments, rotary burs, impression materials, bonding agents, cements, and infection prevention solutions.
Key people
Patrik Eriksson
Senior Vice President · since 2019
Jeffrey S. Kappler
Senior Vice President · since 2019
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
200 South Kraemer Boulevard
Building E
Brea, CA 92821
US
Building E
Brea, CA 92821
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||